4.5 Article

Preparation and characterization of folic acid functionalized bioactive glass for targeted delivery and sustained release of methotrexate

Journal

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Volume 107, Issue 2, Pages 319-329

Publisher

WILEY
DOI: 10.1002/jbm.a.36471

Keywords

bioactive glass; folic acid; methotrexate; targeted drug delivery; sustained release

Funding

  1. Joint Funds of the National Natural Science Foundation of China [U1501245]
  2. Fundamental Research Funds for the Central Universities [2015ZP020]
  3. National Natural Science Foundation of China [51672088]
  4. Science and Technology Innovation Team Project of Foshan [2015IT100062]
  5. Health Care Collaborative Innovation Major Project of Guangzhou [201604020008]

Ask authors/readers for more resources

We have successfully prepared a novel targeted drug delivery system, composed of folic acid (FA) as targeting molecule, methotrexate (MTX) as anticancer drug, and bioactive glass (BG) as carrier. The BG nanoparticles were synthesized by sol-gel method with the dodecylamine as template. The surface of BG nanoparticles was grafted with amino groups by (3-aminopropyl) triethoxysilane, then, FA and MTX were covalently conjugated to the surface of modified BG through amidation reaction, so FA functionalized BG (BG-FA) and targeted drug delivery system (MTX-BG-FA) were prepared. The physicochemical properties of BG, BG-NH2, and BG-FA were characterized by various methods, such as X-ray diffraction, scanning electron microscopy, transmission electron microscopy, Fourier transform infrared spectroscopy, ultraviolet-visible, and so on. Moreover, the drug release results showed that the MTX-BG-FA had sustained release property because of the peptide bond between MTX and BG-FA. And the cytocompatibility evaluation demonstrated that the BG and BG-FA were biocompatible and BG-FA even could promote cell proliferation, while the MTX-BG-FA had high cytotoxicity owning to the sustained release of anticancer drug. From the above, it could be concluded that MTX-BG-FA could kill tumor cells targetedly and sustainedly, which made it a good cancer targeted therapy material. (c) 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 319-329, 2019.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available